Published in Neurology on August 10, 2011
The genetics of dystonia: new twists in an old tale. Brain (2013) 0.98
The genetics of dystonias. Adv Genet (2012) 0.96
Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples. Neurology (2012) 0.88
GLUT1 deficiency syndrome into adulthood: a follow-up study. J Neurol (2014) 0.87
Recent advances in the genetics of dystonia. Curr Neurol Neurosci Rep (2014) 0.84
"Gluing" phenotypes together: the case of GLUT1. Neurology (2011) 0.84
Focal epilepsy in glucose transporter type 1 (Glut1) defects: case reports and a review of literature. J Neurol (2014) 0.76
Genetic Variants Identified from Epilepsy of Unknown Etiology in Chinese Children by Targeted Exome Sequencing. Sci Rep (2017) 0.75
Pediatric movement disorders: Five new things. Neurol Clin Pract (2012) 0.75
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet (2000) 7.20
Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology (2006) 6.44
Differential effects of early hippocampal pathology on episodic and semantic memory. Science (1997) 6.21
De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet (2001) 5.61
Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98
The ubiquitin pathway in Parkinson's disease. Nature (1998) 4.48
Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet (1996) 4.16
Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord (1991) 3.37
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology (2007) 2.72
The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol (1998) 2.72
EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol (2011) 2.63
Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science (1987) 2.48
Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet (1996) 2.40
Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists. Gastroenterology (1985) 2.34
Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology (2009) 2.33
FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J (2000) 2.25
Familial occipitotemporal lobe epilepsy and migraine with visual aura: linkage to chromosome 9q. Neurology (2007) 2.22
High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol (1999) 2.22
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol (2001) 2.20
CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial. Neurology (2001) 2.16
Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology (2010) 2.16
Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology (2004) 2.14
The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain (1998) 2.11
Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations. Neurology (2010) 2.10
Human meiotic recombination products revealed by sequencing a hotspot for homologous strand exchange in multiple HNPP deletion patients. Am J Hum Genet (1998) 2.09
High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology (2006) 2.09
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet (2001) 2.06
Oxidative stress in patients with Friedreich ataxia. Neurology (2000) 2.03
[A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia]. Fortschr Med Orig (2001) 2.02
Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology (2010) 2.01
[Intercultural differences in the treatment of severely injured patients with poor prognosis. Using the example of a 23-year-old Chinese patient]. Unfallchirurg (2013) 1.98
Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A (2000) 1.97
Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development (1995) 1.95
Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J (1985) 1.93
Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain (2009) 1.91
Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology (2007) 1.90
Prevalence of antigliadin antibodies in ataxia patients. Neurology (2003) 1.89
POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology (2004) 1.89
Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements. EMBO J (1987) 1.87
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology (2004) 1.86
Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology (2010) 1.84
Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol (2000) 1.82
Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology (2002) 1.82
Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis. Hum Mol Genet (1993) 1.82
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol (2000) 1.82
Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology (2007) 1.79
CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Neurology (2010) 1.77
Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology (2000) 1.76
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann Neurol (1999) 1.75
Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol (1999) 1.74
Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord (2003) 1.70
The tremor network targeted by successful VIM deep brain stimulation in humans. Neurology (2012) 1.69
Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology (2006) 1.69
Dominant GDAP1 mutations cause predominantly mild CMT phenotypes. Neurology (2011) 1.67
GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology (2012) 1.67
High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res (2001) 1.64
GBA-associated PD presents with nonmotor characteristics. Neurology (2011) 1.63
Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). HMSN Collaborative Research Group. J Med Genet (1992) 1.57
Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology (2008) 1.56
Transformations towards the normal distribution of broad band spectral parameters of the EEG. Electroencephalogr Clin Neurophysiol (1982) 1.55
The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology (2006) 1.54
K(+)-aggravated myotonia: destabilization of the inactivated state of the human muscle Na+ channel by the V1589M mutation. J Physiol (1994) 1.54
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology (2008) 1.53
EEG coherence in Alzheimer disease. Electroencephalogr Clin Neurophysiol (1994) 1.53
Phenotypic expression of the DYT1 mutation: a family with writer's cramp of juvenile onset. Ann Neurol (1998) 1.53
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52
Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ (2010) 1.52
Cervical dystonia in monozygotic twins: case report and review of the literature. Mov Disord (2001) 1.51
The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 procedures. Epilepsy Behav (2008) 1.50
Charcot-Marie-Tooth disease: a clinico-genetic confrontation. Ann Hum Genet (2008) 1.50
TorsinA: movement at many levels. Neuron (2001) 1.49
Skin involvement in amyotrophic lateral sclerosis. Lancet (1996) 1.49
Four generations of epilepsy caused by an inherited microdeletion of the SCN1A gene. Neurology (2010) 1.47
Endovascularly or surgically treated vertebral artery and posterior inferior cerebellar artery aneurysms: clinical analysis and results. Zentralbl Neurochir (2005) 1.45
Proton magnetic resonance spectroscopy in Kennedy syndrome. Arch Neurol (1999) 1.44
Prevention of interferon-stimulated gene expression using microRNA-designed hairpins. Gene Ther (2008) 1.44
Three cases of CLIPPERS: a serial clinical, laboratory and MRI follow-up study. J Neurol (2011) 1.43
Genetic assessment of familial and early-onset Parkinson's disease in a Greek population. Eur J Neurol (2013) 1.43
Sporadic focal dystonia in northwest Germany: molecular basis on chromosome 18p. Ann Neurol (1997) 1.43
Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease. Arch Neurol (2001) 1.42
Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer (2000) 1.41
A novel GABRG2 mutation associated with febrile seizures. Neurology (2006) 1.41
A case of amyotrophic lateral sclerosis with a very slow progression over 44 years. Neuromuscul Disord (2001) 1.40
Simple design for rapid self-injection ictal SPET during aura. Eur J Nucl Med (1999) 1.40
Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain (2003) 1.40
Functional outcome after surgical treatment of intramedullary spinal cord tumors: experience with 78 patients. Spinal Cord (2005) 1.39
Spinocerebellar ataxia type 6: evidence for a strong founder effect among German families. Neurology (1999) 1.39